| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.27B | +83.4% |
| R&D Expense | $172.9M | +15.8% |
| SG&A Expense | $731.7M | -3.1% |
| Operating Income | -$252.9M | +63.4% |
| Interest Expense | $70.3M | +31.0% |
| Pre-tax Income | -$291.1M | +58.5% |
| Income Tax | -$51.7M | — |
| Net Income | -$245.0M | +65.3% |
| EPS (Basic) | -$1.41 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $604.8M | +77.4% |
| Accounts Receivable | $311.2M | +101.0% |
| Inventory | $51.7M | +34.7% |
| Current Assets | $1.17B | +74.8% |
| Total Assets | $2.27B | +145.6% |
| Current Liabilities | $372.4M | +27.9% |
| Total Liabilities | $1.78B | +105.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$218.1M | -15.4% |
| Capital Expenditures | $21.0M | -4.8% |
| Investing Cash Flow | -$398.4M | -205.5% |
| Financing Cash Flow | $884.1M | +78.9% |
| Free Cash Flow | -$239.1M | -13.2% |
| +77.4% |
| EPS (Diluted) | -$1.41 | +77.4% |
| Stockholders' Equity |
| $491.3M |
| +772.1% |